Skip to main content
. 2018 Aug 31;68(4):535–544. doi: 10.1093/cid/ciy540

Figure 2.

Figure 2.

Proportion of participants with Human Immunodeficiency Virus–1 RNA of <50 copies/mL over time (Food and Drug Administration snapshot approach). Abbreviations: CI, confidence interval; DOR/3TC/TDF, doravirine at 100 mg, lamivudine at 300 mg, and tenofovir disoproxil fumarate at 300 mg; EFV/FTC/TDF, efavirenz at 600 mg, emtricitabine at 200 mg, and tenofovir disoproxil fumarate at 300 mg.